RPG Life Sciences Limited
RPGLIFE.NS

$398.22 M
Marketcap
$24.08
Share price
Country
$-0.48
Change (1 day)
$35.25
Year High
$15.31
Year Low

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, anti-spasmodic, etc. It also provides generics primarily in area of immunosuppressant therapy; and finished dosage formulations for various therapies, such as nephrology, rheumatology, oncology, gastroenterology, cardiovascular, diabetology, orthopedics, neuropsychiatry, respiratory, nutritional, general, urology, anti-diabetic, anti-dengue, vitamins and minerals, gynecology and pediatrics, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.

marketcap

RPG Life Sciences Limited (RPGLIFE.NS) - Company Outlook



Company Outlook

Year Receivables Debt Liabilities Assets Current Assets
2023 6.11 M -2,336,380 16.35 M 60.76 M 35.32 M
2022 4.67 M -2,939,431 13.24 M 49.68 M 31.28 M
2021 4.47 M -6,634,750 10.53 M 40.83 M 24.51 M
2020 7.39 M -4,542,434 10.3 M 35.94 M 20.83 M
2019 8 M 1.32 M 10.68 M 31.6 M 14.9 M